BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sebastianutto I, Goyet E, Andreoli L, et al. (2020) D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson's disease. The Journal of Clinical Investigation
Fieblinger T, Zanetti L, Sebastianutto I, et al. (2018) Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068
Sebastianutto I, Cenci MA. (2018) mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia. Current Opinion in Pharmacology. 38: 81-89
Sebastianutto I, Cenci MA, Fieblinger T. (2017) Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease. Neurobiology of Disease
Alcacer C, Andreoli L, Sebastianutto I, et al. (2017) Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy. The Journal of Clinical Investigation
Sebastianutto I, Maslava N, Hopkins CR, et al. (2016) Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists. Neurobiology of Disease
Fieblinger T, Sebastianutto I, Alcacer C, et al. (2014) Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 4728-40
Ohlin KE, Sebastianutto I, Adkins CE, et al. (2012) Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease. Neuroimage. 61: 228-39
See more...